Benzyl (2-sulfamoylethyl)carbamate is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various biologically active compounds, particularly those targeting enzyme inhibition. The sulfamoyl group in its structure makes it valuable for developing molecules with potential therapeutic applications, such as antimicrobial or anticancer agents. Additionally, it is explored in the design of prodrugs, where its carbamate functionality can be leveraged for controlled drug release. Researchers also investigate its role in modifying pharmacokinetic properties of drug candidates, enhancing their stability and bioavailability.